JAVELIN PHARMACEUTICALS

Javelin Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products for the pain management market primarily in the United States and Europe. Its products focus on treating various pain disorders ranging from acute and episodic moderate-to-severe pain associated with breakthrough cancer pain, post-operative pain, post-trauma pain (orthopedic injury pain), procedural pain, and burn pain. The company's Dyloject (injectable dicl... ofenac) received approval for marketing to treat post-operative pain in the United Kingdom and was licensed to Therabel Pharma N.V. for commercialization in the European Union and certain other countries outside the United States. Its products in the Phase 3 development stage in the U.S. include Dyloject (diclofenac sodium injectable), an injectable formulation of diclofenac and a prescription nonsteroidal anti-inflammatory drug that is used to treat post-operative pain due to its combination of effectiveness and tolerability; Ereska (intranasal ketamine), a proprietary nasal formulation; and Rylomine (intranasal morphine) for treatment of acute moderate-to-severe pain, including breakthrough pain. Javelin Pharmaceuticals has license agreements with Shimoda Biotech, Ltd. to develop and commercialize products related to a proprietary formulation of the injectable delivery of diclofenac; and West Pharmaceutical Services, Inc. to develop and commercialize intranasal morphine for the transmucosal delivery of morphine to humans and animals for the treatment of pain. The company was founded in 1998 and is based in Cambridge, Massachusetts.

#SimilarOrganizations #People #Financial #Website #More

JAVELIN PHARMACEUTICALS

Industry:

Biotechnology Developer Platform Pharmaceutical

Founded:

1998-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.javelinpharmaceuticals.com

Total Employee:

11+

Status:

Active

Contact:

617-349-4500

Email Addresses:

[email protected]

Total Funding:

32.75 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Mobile Non Scaleable Content Euro Yoast WordPress SEO Plugin

Similar Organizations

cydex-pharmaceuticals-logo

CyDex Pharmaceuticals

CyDex Pharmaceuticals is a pharmaceutical company that engages in the development and commercialization of drugs specifically designed.

Current Employees Featured

not_available_image

Martin J. Driscoll
Martin J. Driscoll CEO @ Javelin Pharmaceuticals
CEO

fred-mermelstein_image

Fred Mermelstein
Fred Mermelstein Director and Founder @ Javelin Pharmaceuticals
Director and Founder
2009-01-01

not_available_image

Stephen J. Tulipano
Stephen J. Tulipano CFO @ Javelin Pharmaceuticals
CFO

Founder

fred-mermelstein_image

Fred Mermelstein

Investors List

national-cancer-institute_image

Official Site Inspections

http://www.javelinpharmaceuticals.com

Host Informations
Whois Informations

Loading ...